Angiotensin II-dependent hypertension requires cyclooxygenase 1-derived prostaglandin E2 and EP1 receptor signaling in the subfornical organ of the brain

Hypertension

Volumn 59, Issue 4, 2012, Pages 869-876

  Cao, Xian ^a   Peterson, Jeffrey R ^a   Wang, Gang ^a   Anrather, Josef ^a   Young, Colin N ^b   Guruju, Mallikarjuna R ^a   Burmeister, Melissa A ^b   Iadecola, Costantino ^a   Davisson, Robin L ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

blood pressure; central nervous system; COX; PGE 2; prostanoids; reactive oxygen species

Indexed keywords

ANGIOTENSIN II; CYCLOOXYGENASE 1; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; REACTIVE OXYGEN METABOLITE; SC 51089; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; HYPERTENSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUBFORNICAL ORGAN; TELEMETRY;

ANGIOTENSIN II; ANIMALS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; DISEASE MODELS, ANIMAL; HYDRAZINES; HYPERTENSION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXAZEPINES; REACTIVE OXYGEN SPECIES; RECEPTOR CROSS-TALK; RECEPTORS, PROSTAGLANDIN E, EP1 SUBTYPE; SIGNAL TRANSDUCTION; SUBFORNICAL ORGAN;

EID: 84862805913     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.182071     Document Type: Article

References (35)

1. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 2007;49:69-75. (Pubitemid 46360343)
2. Smyth EM, Grosser T, Wang M, Yu Y, FitzGerald GA. Prostanoids in health and disease. J Lipid Res. 2009;50(suppl)S423-S428.
3. Grosser T, Fries S, FitzGerald GA. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest. 2006;116:4-15. (Pubitemid 43121782)
4. Kobayashi T, Narumiya S. Narumiya S. Function of prostanoid receptors: studies on knockout mice. Prostaglandins Other Lipid Mediat. 2002; 68-69:557-573. (Pubitemid 35247420)
5. Capone C, Faraco G, Anrather J, Zhou P, Iadecola C. Cyclooxygenase 1-derived prostaglandin E2 and EP1 receptors are required for the cerebrovascular dysfunction induced by angiotensin II. Hypertension. 2010; 55:911-917.
6. Suganami T, Mori K, Tanaka I, Mukoyama M, Sugawara A, Makino H, Muro S, Yahata K, Ohuchida S, Maruyama T, Narumiya S, Nakao K. Role of prostaglandin E receptor EP1 subtype in the development of renal injury in genetically hypertensive rats. Hypertension. 2003;42: 1183-1190. (Pubitemid 37549075)
7. Rutkai I, Feher A, Erdei N, Henrion D, Papp Z, Edes I, Koller A, Kaley G, Bagi Z. Activation of prostaglandin E2 EP1 receptor increases arteriolar tone and blood pressure in mice with type 2 diabetes. Cardiovasc Res. 2009;83:148-154.
8. Guan Y, Zhang Y, Wu J, Qi Z, Yang G, Dou D, Gao Y, Chen L, Zhang X, Davis LS, Wei M, Fan X, Carmosino M, Hao C, Imig JD, Breyer RM, Breyer MD. Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting. J Clin Invest. 2007;117:2496-2505. (Pubitemid 47494351)
9. Osborn JW, Fink GD, Sved AF, Toney GM, Raizada MK. Circulating angiotensin II and dietary salt: converging signals for neurogenic hypertension. Curr Hypertens Rep. 2007;9:228-235. (Pubitemid 46900043)
10. Cottrell GT, Ferguson AV. Sensory circumventricular organs: central roles in integrated autonomic regulation. Regul Pept. 2004;117:11-23. (Pubitemid 37548394)
11. Zimmerman MC, Lazartigues E, Sharma RV, Davisson RL. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res. 2004;95:210-216. (Pubitemid 38988688)
12. Hendel MD, Collister JP. Contribution of the subfornical organ to angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol. 2005; 288:H680-H685. (Pubitemid 40139650)
13. Smith PM, Ferguson AV. Circulating signals as critical regulators of autonomic state-central roles for the subfornical organ. Am J Physiol Regul Integr Comp Physiol. 2010;299:R405-R415.
14. Peterson JR, Burmeister MA, Tian X, Zhou Y, Guruju MR, Stupinski JA, Sharma RV, Davisson RL. Genetic silencing of Nox2 and Nox4 reveals differential roles of these NADPH oxidase homologues in the vasopressor and dipsogenic effects of brain angiotensin II. Hypertension. 2009;54: 1106-1114.
15. Lob HE, Marvar PJ, Guzik TJ, Sharma S, McCann LA, Weyand C, Gordon FJ, Harrison DG. Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system. Hypertension. 2010;55:277-283.
16. Zimmerman MC, Lazartigues E, Lang JA, Sinnayah P, Ahmad IM, Spitz DR, Davisson RL. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res. 2002;91:1038-1045. (Pubitemid 35416641)
17. Kawano T, Anrather J, Zhou P, Park L, Wang G, Frys KA, Kunz A, Cho S, Orio M, Iadecola C. Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat Med. 2006;12:225-229. (Pubitemid 43214750)
18. Wang G, Anrather J, Glass MJ, Tarsitano MJ, Zhou P, Frys KA, Pickel VM, Iadecola C. Nox2, Ca2, and protein kinase C play a role in angiotensin II-induced free radical production in nucleus tractus solitarius. Hypertension. 2006;48:482-489. (Pubitemid 44253744)
19. Capone C, Faraco G, Park L, Cao X, Davisson RL, Iadecola C. The cerebrovascular dysfunction induced by slow pressor doses of angiotensin II precedes the development of hypertension. Am J Physiol Heart Circ Physiol. 2011;300:H397-H407.
20. Cheng HF, Harris RC. Cyclooxygenases, the kidney, and hypertension. Hypertension. 2004;43:525-530. (Pubitemid 38282421)
21. Baudrie V, Laude D, Elghozi JL. Optimal frequency ranges for extracting information on cardiovascular autonomic control from the blood pressure and pulse interval spectrograms in mice. Am J Physiol Regul Integr Comp Physiol. 2007;292:R904-R912. (Pubitemid 46207747)
22. Fitzsimons JT. Angiotensin, thirst, and sodium appetite. Physiol Rev. 1998;78:583-686. (Pubitemid 28340599)
23. Datla SR, Griendling KK. Reactive oxygen species, NADPH oxidases, and hypertension. Hypertension. 2010;56:325-330.
24. Qi Z, Hao CM, Langenbach RI, Breyer RM, Redha R, Morrow JD, Breyer MD. Opposite effects of cyclooxygenase-1 and-2 activity on the pressor response to angiotensin II. J Clin Invest. 2002;110:61-69. (Pubitemid 34743466)
25. Qi Z, Cai H, Morrow JD, Breyer MD. Differentiation of cyclooxygenase 1-and 2-derived prostanoids in mouse kidney and aorta. Hypertension. 2006;48:323-328. (Pubitemid 44309830)
26. Tanioka T, Nakatani Y, Semmyo N, Murakami M, Kudo I. Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J Biol Chem. 2000;275:32775-32782.
27. Candelario-Jalil E, Slawik H, Ridelis I, Waschbisch A, Akundi RS, Hull M, Fiebich BL. Regional distribution of the prostaglandin E2 receptor EP1 in the rat brain: accumulation in purkinje cells of the cerebellum. J Mol Neurosci. 2005;27:303-310. (Pubitemid 41572677)
28. Matsumura K, Watanabe Y, Imai-Matsumura K, Connolly M, Koyama Y, Onoe H. Mapping of prostaglandin E2 binding sites in rat brain using quantitative autoradiography. Brain Res. 1992;581:292-298.
29. Leung KH, Chang RS, Lotti VJ, Roscoe WA, Smith RD, Timmermans PB, Chiu AT. AT1 receptors mediate the release of prostaglandins in porcine smooth muscle cells and rat astrocytes. Am J Hypertens. 1992; 5:648-656.
30. Jaiswal N, Diz DI, Tallant EA, Khosla MC, Ferrario CM. Characterization of angiotensin receptors mediating prostaglandin synthesis in C6 glioma cells. Am J Physiol. 1991;260:R1000-R1006.
31. Matsumura K, Watanabe Y, Onoe H, Hayaishi O. High density of prostaglandin E2 binding sites in the anterior wall of the III ventricle: a possible site of its hyperthermic action. Brain Res. 1990;533:147-151. (Pubitemid 20375811)
32. Pimenta E, Oparil S. Prehypertension: epidemiology, consequences and treatment. Nat Rev Nephrol. 2010;6:21-30.
33. Zhang W, Mifflin S. Plasticity of GABAergic mechanisms within the nucleus of the solitary tract in hypertension. Hypertension. 2010;55: 201-206.
34. Zimmerman MC, Dunlay RP, Lazartigues E, Zhang Y, Sharma RV, Engelhardt JF, Davisson RL. Requirement for rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ Res. 2004;95:532-539. (Pubitemid 39180933)
35. Breyer MD, Breyer RM. Prostaglandin E receptors and the kidney. Am J Physiol Renal Physiol. 2000;279:F12-F23. (Pubitemid 30619543)